BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14709151)

  • 1. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R.
    Watanabe M; Nakajin S
    J Endocrinol; 2004 Jan; 180(1):125-33. PubMed ID: 14709151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
    Watanabe M; Noda M; Nakajin S
    J Endocrinol; 2006 Jan; 188(1):59-68. PubMed ID: 16394175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO.
    Watanabe M; Ohno S; Nakajin S
    Eur J Endocrinol; 2005 Apr; 152(4):619-24. PubMed ID: 15817919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.
    Caron-Beaudoin É; Denison MS; Sanderson JT
    Toxicol Sci; 2016 Jan; 149(1):134-44. PubMed ID: 26464060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?
    Sanderson JT; Seinen W; Giesy JP; van den Berg M
    Toxicol Sci; 2000 Mar; 54(1):121-7. PubMed ID: 10746939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
    Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
    Sanderson T; Renaud M; Scholten D; Nijmeijer S; van den Berg M; Cowell S; Guns E; Nelson C; Mutarapat T; Ruchirawat S
    Eur J Pharmacol; 2008 Sep; 593(1-3):92-8. PubMed ID: 18639541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen biosynthesis in human H295 adrenocortical carcinoma cells.
    Nicol MR; Papacleovoulou G; Evans DB; Penning TM; Strachan MW; Advani A; Johnson SJ; Quinton R; Mason JI
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):115-20. PubMed ID: 19026713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase expression in the normal human adult adrenal and in adrenocortical tumors: biochemical, immunohistochemical, and molecular studies.
    Moreau F; Mittre H; Benhaim A; Bois C; Bertherat J; Carreau S; Reznik Y
    Eur J Endocrinol; 2009 Jan; 160(1):93-9. PubMed ID: 18974231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactions, phosphorylation, and levels of 3',5'-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells.
    Carlone DL; Richards JS
    Mol Endocrinol; 1997 Mar; 11(3):292-304. PubMed ID: 9058376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
    Zeitoun K; Takayama K; Michael MD; Bulun SE
    Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.
    Zhao Y; Mendelson CR; Simpson ER
    Mol Endocrinol; 1995 Mar; 9(3):340-9. PubMed ID: 7776980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inducible isoform of CREM (inducible cAMP early repressor, ICER) is a repressor of CYP19 rat ovarian promoter.
    Morales V; Gonzalez-Robayna I; Hernandez I; Quintana J; Santana P; Ruiz de Galarreta CM; Fanjul LF
    J Endocrinol; 2003 Dec; 179(3):417-25. PubMed ID: 14656211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells.
    Lin X; Takemori H; Katoh Y; Doi J; Horike N; Makino A; Nonaka Y; Okamoto M
    Mol Endocrinol; 2001 Aug; 15(8):1264-76. PubMed ID: 11463852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of transcription factor GATA-4 in regulation of CYP19 gene during folliculogenesis and luteinization in buffalo ovary.
    Monga R; Ghai S; Datta TK; Singh D
    J Steroid Biochem Mol Biol; 2012 May; 130(1-2):45-56. PubMed ID: 22245270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5'-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclic adenosine 3',5'-monophosphate-like responsive sequence.
    Hinshelwood MM; Michael MD; Simpson ER
    Endocrinology; 1997 Sep; 138(9):3704-10. PubMed ID: 9275055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mono-(2-ethylhexyl) phthalate induces NR4A subfamily and GIOT-1 gene expression, and suppresses CYP19 expression in human granulosa-like tumor cell line KGN.
    Ohno S; Yukinawa F; Noda M; Nakajin S
    Toxicol Lett; 2009 Dec; 191(2-3):353-9. PubMed ID: 19822197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter activity and chromosomal location of the Rana rugosa P450 aromatase (CYP19) gene.
    Oshima Y; Kato T; Wang D; Murakami T; Matsuda Y; Nagahama Y; Nakamura M
    Zoolog Sci; 2006 Jan; 23(1):79-85. PubMed ID: 16547409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.